EFPIA - NEWSLETTER

EFPIA Newsletter 14 February 2019

Diabetes partnership powering a healthier future

Winner of 2018 Prevention & Awareness Category

KiDS and Diabetes in Schools won the Prevention & Awareness Category at the 2018 Health Collaboration Awards.

Around one in five people in Europe is an unhealthy weight, putting them at increased risk of diabetes. Poland is a case in point. More than 20% of primary and secondary school children in Poland are overweight.

The KiDS and Diabetes in Schools, an educational programme, was co-created by the International Diabetes Federation (IDF), the International Society for Pediatric and Adolescent Diabetes (ISPAD) and Sanofi. The goal was to make schools a safe and supportive environment for children with diabetes, to fight discrimination, and to prevent type 2 diabetes through education on lifestyle choices.

News

14 February 2019 Europe’s gamble with the future of medical innovation

EFPIA notes the gamble on Europe’s future in medical innovation taken by the EU institutions in today’s trilogue meeting...

08 February 2019 Medicines verification system goes live across EU to better protect patients from falsified...

The new system is a world-first for its stakeholder model, its scale, its use of new technologies and represents an...

Blogs

14 February 2019 Stimulating the development of new medicines for children

WeWontRest in our commitment to working with our partners in paediatric research to continue to discover, develop and...

08 February 2019 Highlights from DIA Europe 2019 – EFPIA team in the Middle of the Regulatory Buzz

A blog by: Magda Chlebus, Sini Eskola, Nathalie Moll, Jana Nackberg, Giovanna Rizzetto and Pär Tellner

14 February 2019 There is plenty of buzz around genomics yet access to testing and treatments is still a challenge...

How can Europe ensure that also European cancer patients benefit from those new treatments?

08 February 2019 European Medicines Verification System – is it worth it?

When it comes to patient safety, what level of risk are you willing to accept? What number is an acceptable number?

Videos

Children keep us up at night

And #WeWontRest until we’ve helped make the world a healthier place for every single one of them.

For The Chance To...

Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.

Events

08 MAY 2019

2019 China/EU Pharmaceutical Industry Forum Hangzhou, China

The workshop covers 4 different themes: Pharmaceuticals in the Environment, Pricing & Reimbursement, Compliance (marketing...

Learn more →

02 MAY 2019

ICHOM conference 2019 Rotterdam, The Netherlands

The world-leading event for providers, life sciences and industry on value-based healthcare

Learn more →

What we are reading

EU institutions reach deal on SPC waiver 14 February 2019 (Politico Pro)

EU pharma stakeholders take action to tackle fake medicines 11 February 2019 (Euractiv)

UK government acknowledges delayed access to new drugs in no-deal Brexit 11 February 2019 (Politico Pro)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶